Novo Nordisk Charges Its Insulin Patents Infringed on by Pfizer’s Exubera

Drug Industry Daily
KEYWORDS courts / Lawsuit
A A

Novo Nordisk has filed a patent infringement suit claiming Pfizer’s inhaled insulin product Exubera infringes on five of its insulin delivery patents.

To View This Article:

Login

Subscribe To Drug Industry Daily